11-64747224-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_005609.4(PYGM):c.2312G>A(p.Arg771Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005609.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PYGM | NM_005609.4 | c.2312G>A | p.Arg771Gln | missense_variant, splice_region_variant | 18/20 | ENST00000164139.4 | NP_005600.1 | |
PYGM | NM_001164716.1 | c.2048G>A | p.Arg683Gln | missense_variant, splice_region_variant | 16/18 | NP_001158188.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYGM | ENST00000164139.4 | c.2312G>A | p.Arg771Gln | missense_variant, splice_region_variant | 18/20 | 1 | NM_005609.4 | ENSP00000164139.3 | ||
PYGM | ENST00000377432.7 | c.2048G>A | p.Arg683Gln | missense_variant, splice_region_variant | 16/18 | 2 | ENSP00000366650.3 | |||
PYGM | ENST00000483742.1 | n.1665G>A | splice_region_variant, non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251458Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135914
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727154
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74372
ClinVar
Submissions by phenotype
Glycogen storage disease, type V Pathogenic:4Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 771 of the PYGM protein (p.Arg771Gln). This variant also falls at the last nucleotide of exon 18, which is part of the consensus splice site for this exon. This variant is present in population databases (rs150911354, gnomAD 0.005%). This missense change has been observed in individual(s) with glycogen storage disease (PMID: 19670320, 21802952, 34534370, 35022222; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 430153). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Columbia University Laboratory of Personalized Genomic Medicine, Columbia University Medical Center | Oct 11, 2021 | The c. 2312G>A(p.Arg771Gln) variant identified in this individual is a missense variant in coding exon 18/20 that substitutes a conserved arginine residue to glutamine at amino acid 771/843. In silico methods predict this variant to be tolerated/damaging (SIFT: 0.165; Provean:-3.38) to protein function. This variant is also predicted to affect splicing as it lies in the last nucleotide of exon 18, which is part of the consensus splice donor site for this exon (Trap Score: 0.989; dbscSNV: 0.9999). This variant is present at an allele frequency of 2/282862, zero homozygotes in gnomAD exomes and genomes, suggesting that it is not a common benign variant in the populations represented in these databases. This variant has been previously reported in affected individuals, once homozygous, once compound heterozygous with the pathogenic p.Arg50Ter PYGM variant (Nadaj-Pakleza, 2009; Vieitez, 2011), and was detected homozygous from proband only clinical WES in an affected individual at CUMC. Based on the currently available evidence, we classify this variant as likely pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 02, 2023 | - - |
Uncertain significance, flagged submission | clinical testing | Counsyl | Aug 30, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PP3_Moderate+PM3_Strong - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 21, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 18846642, 19670320, 35022222, 34534370, 21802952) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at